Role of liver transportation in the treatment of cholangiocarcinoma

Amit Singal, Theodore H. Welling, Jorge A. Marrero

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Cholangiocarcinoma is a rare malignancy arising from the bile duct epithelium with a grim prognosis. Although complete resection may be curative, it is feasible only in a minority of cases owing to local extension of the tumor. Early experiences with liver transplantation were discouraging, given the high rates of tumor recurrence and poor patient survival. Trials with aggressive transplantation methods and adjuvant chemotherapy did not yield significantly better outcomes. Recently, stringent patient selection and neoadjuvant chemoradiation have yielded promising results with 5-year survival rates as high as 76%. Factors associated with recurrence after transplantation include advanced age, history of cholecystectomy, elevated serum glycoprotein cancer antigen 19-9 level, a discreet mass on imaging and an interval from enrollment to transplant greater than 100 days.

Original languageEnglish (US)
Pages (from-to)491-502
Number of pages12
JournalExpert Review of Anticancer Therapy
Volume9
Issue number4
DOIs
StatePublished - 2009

Fingerprint

Cholangiocarcinoma
Liver
Neoplasms
Transplantation
Recurrence
Cholecystectomy
Therapeutics
Adjuvant Chemotherapy
Bile Ducts
Liver Transplantation
Patient Selection
Glycoproteins
Survival Rate
Epithelium
Transplants
Antigens
Survival
Serum

Keywords

  • Bile duck cancer
  • Cholangiocarcinoma
  • Liver transportation
  • Neoadjuvant chemotherapy
  • Prognosis

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Oncology

Cite this

Role of liver transportation in the treatment of cholangiocarcinoma. / Singal, Amit; Welling, Theodore H.; Marrero, Jorge A.

In: Expert Review of Anticancer Therapy, Vol. 9, No. 4, 2009, p. 491-502.

Research output: Contribution to journalArticle

@article{379ee07585224b6ab966940141211f05,
title = "Role of liver transportation in the treatment of cholangiocarcinoma",
abstract = "Cholangiocarcinoma is a rare malignancy arising from the bile duct epithelium with a grim prognosis. Although complete resection may be curative, it is feasible only in a minority of cases owing to local extension of the tumor. Early experiences with liver transplantation were discouraging, given the high rates of tumor recurrence and poor patient survival. Trials with aggressive transplantation methods and adjuvant chemotherapy did not yield significantly better outcomes. Recently, stringent patient selection and neoadjuvant chemoradiation have yielded promising results with 5-year survival rates as high as 76{\%}. Factors associated with recurrence after transplantation include advanced age, history of cholecystectomy, elevated serum glycoprotein cancer antigen 19-9 level, a discreet mass on imaging and an interval from enrollment to transplant greater than 100 days.",
keywords = "Bile duck cancer, Cholangiocarcinoma, Liver transportation, Neoadjuvant chemotherapy, Prognosis",
author = "Amit Singal and Welling, {Theodore H.} and Marrero, {Jorge A.}",
year = "2009",
doi = "10.1586/ERA.09.5",
language = "English (US)",
volume = "9",
pages = "491--502",
journal = "Expert Review of Anticancer Therapy",
issn = "1473-7140",
publisher = "Expert Reviews Ltd.",
number = "4",

}

TY - JOUR

T1 - Role of liver transportation in the treatment of cholangiocarcinoma

AU - Singal, Amit

AU - Welling, Theodore H.

AU - Marrero, Jorge A.

PY - 2009

Y1 - 2009

N2 - Cholangiocarcinoma is a rare malignancy arising from the bile duct epithelium with a grim prognosis. Although complete resection may be curative, it is feasible only in a minority of cases owing to local extension of the tumor. Early experiences with liver transplantation were discouraging, given the high rates of tumor recurrence and poor patient survival. Trials with aggressive transplantation methods and adjuvant chemotherapy did not yield significantly better outcomes. Recently, stringent patient selection and neoadjuvant chemoradiation have yielded promising results with 5-year survival rates as high as 76%. Factors associated with recurrence after transplantation include advanced age, history of cholecystectomy, elevated serum glycoprotein cancer antigen 19-9 level, a discreet mass on imaging and an interval from enrollment to transplant greater than 100 days.

AB - Cholangiocarcinoma is a rare malignancy arising from the bile duct epithelium with a grim prognosis. Although complete resection may be curative, it is feasible only in a minority of cases owing to local extension of the tumor. Early experiences with liver transplantation were discouraging, given the high rates of tumor recurrence and poor patient survival. Trials with aggressive transplantation methods and adjuvant chemotherapy did not yield significantly better outcomes. Recently, stringent patient selection and neoadjuvant chemoradiation have yielded promising results with 5-year survival rates as high as 76%. Factors associated with recurrence after transplantation include advanced age, history of cholecystectomy, elevated serum glycoprotein cancer antigen 19-9 level, a discreet mass on imaging and an interval from enrollment to transplant greater than 100 days.

KW - Bile duck cancer

KW - Cholangiocarcinoma

KW - Liver transportation

KW - Neoadjuvant chemotherapy

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=67650296557&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650296557&partnerID=8YFLogxK

U2 - 10.1586/ERA.09.5

DO - 10.1586/ERA.09.5

M3 - Article

C2 - 19374602

AN - SCOPUS:67650296557

VL - 9

SP - 491

EP - 502

JO - Expert Review of Anticancer Therapy

JF - Expert Review of Anticancer Therapy

SN - 1473-7140

IS - 4

ER -